Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

2023148 citationsReviewhybrid Open Access

Authors

Silke Gillessen · Università della Svizzera italiana

Alberto Bossi

Ian D. Davis · Monash University

Johann S. de Bono · Institute of Cancer Research

Karim Fizazi · Institut Gustave Roussy

Nicholas D. James · Institute of Cancer Research

Nicolas Mottet · Université Jean Monnet

Abstract

At APCCC 2022, clinically important questions in the management of advanced prostate cancer management were identified and discussed, and experts voted on pre-defined consensus questions. The report of the results for metastatic and/or castration-resistant prostate cancer is summarised here.

Topics & Keywords

Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Cancer, Lipids, and Metabolism

Publication Details

Published in: European Journal of Cancer

Volume 185, pp. 178-215

DOI: 10.1016/j.ejca.2023.02.018

Field-Weighted Citation Impact: 38.06

Command Palette

Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

Authors

Abstract

Topics & Keywords

Publication Details